Vcanbio Cell&Gene Engineering Corp.,Ltd’s Net Profit Dropped 20.9% in First Quarter of 2022

Vcanbio Cell&Gene Engineering Corp.,Ltd (中源协和细胞基因工程股份有限公司) (600645.SH) reported a net profit of 36.2 million yuan in the first quarter of 2022, down 20.9% year-on-year.

Meanwhile, the company posted 394.2 million yuan in revenue, up 7.5% year-on-year.

At the end of the reporting period, it had 5 billion yuan in total assets and 1.6 billion yuan in total liabilities, with a liability-to-asset ratio of 30.8%.